Mitral valve repair with the semi-rigid Memo 4D annuloplasty ring: early clinical and echocardiographic outcomes from the MANTRA study.

0 CARDIAC & CARDIOVASCULAR SYSTEMS Interdisciplinary cardiovascular and thoracic surgery Pub Date : 2024-12-25 DOI:10.1093/icvts/ivae208
Omer Dzemali, Hector Rodriguez Cetina Biefer, Marco Di Eusanio, Olivier Fabre, Giovanni Troise, Nikolaos Bonaros, Francesco Grimaldi, Yeong-Hoon Choi, Giuseppe Santarpino, Cristian Baeza, Francesco Pollari, Bertrand Marcheix, Davide Pacini, Vincenzo Argano, Max Baghai, Moninder Bhabra, Enzo Mazzaro, Luigi Badano, Joerg Kempfert
{"title":"Mitral valve repair with the semi-rigid Memo 4D annuloplasty ring: early clinical and echocardiographic outcomes from the MANTRA study.","authors":"Omer Dzemali, Hector Rodriguez Cetina Biefer, Marco Di Eusanio, Olivier Fabre, Giovanni Troise, Nikolaos Bonaros, Francesco Grimaldi, Yeong-Hoon Choi, Giuseppe Santarpino, Cristian Baeza, Francesco Pollari, Bertrand Marcheix, Davide Pacini, Vincenzo Argano, Max Baghai, Moninder Bhabra, Enzo Mazzaro, Luigi Badano, Joerg Kempfert","doi":"10.1093/icvts/ivae208","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Memo 4D is a semi-rigid ring with an exclusive saddle shape and progressive increased anteroposterior diameter. This preliminary analysis reports 30-day clinical and haemodynamic outcomes of the MANTRA Memo 4D sub-study.</p><p><strong>Methods: </strong>MANTRA is an 'umbrella' prospective, multicentre, worldwide post-market study to collect real-life safety and performance data on the Corcym devices. Clinical and echocardiographic outcomes were gathered preoperatively, at discharge and each follow-up. KCCQ-12 questionnaires were collected preoperatively and at 30 days. Echocardiographic studies were performed per a predefined protocol and assessed by an independent core laboratory.</p><p><strong>Results: </strong>In total, 166 patients (52, 31.3% female, mean age 60.7 ± 11.4 years) underwent mitral valve repair with Memo 4D in 17 international institutions between July 2021 and June 2023 (enrolment is still ongoing). Primary was the most common aetiology (157, 94.6%), of which 33 cases of Barlow's disease (19.9%); secondary mitral regurgitation was present in six cases (3.6%). Thirty-day mortality was 0.6% (1). One stroke event (0.6%), one acute kidney failure (0.6%), one myocardial infarction (0.6%) and two reoperations within 30 days were reported. Surgery marked improvement in the patient's NYHA class associated with a significant increase in KCCQ-12 summary score, from 69.1 (SD = 23.7) preoperatively to 83.9 (SD = 15.7) at 30 days. End-diastolic left ventricular diameters decreased from 55.19 (SD = 7.10) preoperatively to 52.70 (SD = 3.76) mm at 30 days, and left atrial volume decreased from 125.79 (SD = 46.33) preoperatively to 91.51 (SD = 37.20) ml at 30 days. Mitral regurgitation significantly reduced after the operation and up to 30-day follow-up.</p><p><strong>Conclusions: </strong>Mitral valve repair with Memo 4D is associated with good clinical and haemodynamic outcomes in the early period.MANTRA ClinicalTrials.gov number NCT05002543.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivae208","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Memo 4D is a semi-rigid ring with an exclusive saddle shape and progressive increased anteroposterior diameter. This preliminary analysis reports 30-day clinical and haemodynamic outcomes of the MANTRA Memo 4D sub-study.

Methods: MANTRA is an 'umbrella' prospective, multicentre, worldwide post-market study to collect real-life safety and performance data on the Corcym devices. Clinical and echocardiographic outcomes were gathered preoperatively, at discharge and each follow-up. KCCQ-12 questionnaires were collected preoperatively and at 30 days. Echocardiographic studies were performed per a predefined protocol and assessed by an independent core laboratory.

Results: In total, 166 patients (52, 31.3% female, mean age 60.7 ± 11.4 years) underwent mitral valve repair with Memo 4D in 17 international institutions between July 2021 and June 2023 (enrolment is still ongoing). Primary was the most common aetiology (157, 94.6%), of which 33 cases of Barlow's disease (19.9%); secondary mitral regurgitation was present in six cases (3.6%). Thirty-day mortality was 0.6% (1). One stroke event (0.6%), one acute kidney failure (0.6%), one myocardial infarction (0.6%) and two reoperations within 30 days were reported. Surgery marked improvement in the patient's NYHA class associated with a significant increase in KCCQ-12 summary score, from 69.1 (SD = 23.7) preoperatively to 83.9 (SD = 15.7) at 30 days. End-diastolic left ventricular diameters decreased from 55.19 (SD = 7.10) preoperatively to 52.70 (SD = 3.76) mm at 30 days, and left atrial volume decreased from 125.79 (SD = 46.33) preoperatively to 91.51 (SD = 37.20) ml at 30 days. Mitral regurgitation significantly reduced after the operation and up to 30-day follow-up.

Conclusions: Mitral valve repair with Memo 4D is associated with good clinical and haemodynamic outcomes in the early period.MANTRA ClinicalTrials.gov number NCT05002543.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用半刚性 MEMO 4D 瓣环进行二尖瓣修复:MANTRA 研究的早期临床和超声心动图结果。
目的:Memo 4D是一种半刚性环,具有独特的鞍形,前后直径逐渐增加。本初步分析报告了MANTRA Memo 4D亚研究的30天临床和血流动力学结果。方法:MANTRA是一项“伞形”前瞻性、多中心、全球上市后研究,旨在收集Corcym器械的实际安全性和性能数据。收集术前、出院时和每次随访时的临床和超声心动图结果。术前和术后30天分别收集KCCQ-12问卷。超声心动图研究按照预先确定的方案进行,并由独立的核心实验室进行评估。结果:在2021年7月至2023年6月期间,17家国际机构的166例患者(52例,女性31.3%,平均年龄60.7±11.4岁)接受了Memo 4D二尖瓣修复术(招募仍在进行中)。原发病因最多(157例,94.6%),其中巴洛病33例(19.9%);继发性二尖瓣返流6例(3.6%)。30天死亡率为0.6%(1)。30天内报告1例卒中(0.6%)、1例急性肾衰竭(0.6%)、1例心肌梗死(0.6%)和2例再手术。手术显著改善了患者的NYHA分级,KCCQ-12总评分显著增加,从术前的69.1 (SD 23.7)增加到30天的83.9 (SD 15.7)。舒张末期左室直径由术前的55.19 (SD 7.10) mm降至30 d时的52.70 (SD 3.76) mm,左房容积由术前的125.79 (SD 46.33) ml降至30 d时的91.51 (SD 37.20) ml。手术后二尖瓣返流明显减少,随访30天。结论:Memo 4D二尖瓣修复术早期具有良好的临床和血流动力学预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Computational fluid dynamics to simulate stenotic lesions in coronary end-to-side anastomosis. Long-term retention of the pedicled thymic flap after bronchial stump coverage. Closure of ventricular septal defect in children with trisomy 18: perioperative events and long-term survival. Intraoperative aortic dissection in a patient with cervical aortic arch. Hyperacute silicosis after bronchoscopy-induced melanoptysis in a lung transplant patient. A first report in literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1